Letters to the Editor

Menopause

Volumn 10, Issue 1, 2003, Pages 103-105

  Kuhl, Herbert ^a   Wiegratz, Inka ^a  

^a Department of Obstetrics and Gynecology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874297752     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/00042192-200310010-00017     Document Type: Letter

References (24)

1. Reed MJ, Ross MS, Lai LC, et al. in vivo conversion of norethisterone to ethynyloestradiol in perimenopausal women. J Steroid Biochem Molec Biol 1990; 37:301-303.
2. Klehr-Bathmann I, Kuhl H. Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate. Maturitas 1995; 21:245-250.
3. Kuhnz W, Heuner A, Hümpel M, et al. in vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women. Contraception 1997; 56:379-385.
4. Beier S, Düsterberg B, El Etreby MF, et al. Toxicology of hormonal fertility-regulating agents. In: Benagiano G, Diczfalusy E, eds. Endocrine Mechanisms in Fertility Regulation New York, NY: Raven Press, 1983;261-346.
5. Schoonen WGEJ, Deckers GH, de Gooijer ME, et al. Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives. J Steroid Biochem Molec Biol 2000; 74:213-222.
6. LaMorte A, Kumar N, Bardin CW, et al. Aromatization of 7alpha-methyl-19-nortestosterone by human placental microsomes in vitro. J Steroid Biochem Molec Biol 1994; 48:297-304.
7. Kloosterboer HJ. Tibolone and its metabolites: pharmacology, tissue specificity and effects in animal model of tumors. Gynecol Endocrinol 1997; 11(Suppl 1):63-68.
8. Wiegratz I, Sänger N, Kuhl H. Formation of 7α-methyl-ethinyl estradiol during treatment with tibolone. Menopause 2002; 9:293-295.
9. Kuhnz W, Sostarek D, Gansau C, et al. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum. Am J Obstet Gynecol 1991; 165:596-602.
10. Jung-Hoffmann C, Kuhl H. Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism. Am J Obstet Gynecol 1990; 163:2183-2197.
11. Simpson ER, Clyne C, Rubin G, et al. Aromatase - a brief overview. Annu Rev Physiol 2002; 64:93-137.
12. th International Symposium on Steroid Biochemistry & Molecular Biology; May 18-20, 2002; Munich, Germany.
13. th International Symposium on Steroid Biochemistry & Molecular Biology, May 18-20, 2002; Munich, Germany.
14. Smuk M, Schwers J. Aromatization of androstenedione by human adult liver in vitro. J Clin Endocrinol Metab 1977; 45:1009-1012.
15. Shimada K, Mitamura K, Higashi T. Gas chromatography and high-performance liquid chromatography of natural steroids. J Chromatography A 2001; 935:141-172.
16. Vos RME, Krebbers SFM, Verhoeven CHJ, et al. The in vivo human metabolism of tibolone. Drug Metab Dispos 2002; 30:106-112.
17. Bodine PVN, Harris HA, Lyttle CR, et al. Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite. Steroids 2002; 67:681-686.
18. Larsson-Cohn U, Fahraeus L, Wallentin L, et al. Effects of the estrogenicity of levonorgestrel/ethinylestradiol combinations on the lipoprotein status. Acta Obstet Gynecol Scand Suppl 1982; 105:37-40.
19. Lemus AE, Enriquez J, Garcia GA, et al. 5alpha-reduction of norethisterone enhances its binding affinity for androgenic receptors but diminishes its androgenic potency. J Steroid Biochem Molec Biol 1997; 60:121-129.
20. Zhou J, Ng S, Adesanya-Famuiya, et al. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 2000; 14:1725-1730.
21. Tang B, Markiewicz L, Kloosterboer HJ, et al. Human endometrial 3β-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestogenic activity ratios of a steroidal drug (Org OD 14). J Steroid Biochem Molec Biol 1993; 45:345-351.
22. Okon MA, Lee S, Laird SM, et al. A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of period-free hormone replacement therapy. Hum Reprod 1998; 13:2261-2265.
23. Goldzieher JW, de la Pena A, Chenault CB, et al. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Am J Obstet Gynecol 1975; 122:625-636.
24. Franchimont P, Franchi F, Luisi M, et al. Ovulation-inhibiting properties of Org OD 14. Reproduccion 1982; 6:61-67.